Flumezapine Hydrochloride
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Flumezapine Hydrochloride Product Information
Flumezapine Hydrochloride is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Flumezapine. The product is supplied by Clearsynth under CAT No. CS-O-01561.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Flumezapine Hydrochloride
CAT No.
CS-O-01561
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C17H2ClFN4S
Molecular Weight
366.89
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Flumezapine Hydrochloride is supplied with detailed characterization data compliant with regulatory guideline. Flumezapine Hydrochloride can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Flumezapine.
Overview
"Flumezapine Hydrochloride is used in the treatment of chronic psychoses such as schizophrenia, and appears to be about equal in effectiveness to low-potency antipsychotics."
Synonyms
Flumezapine Hydrochloride
Application Notes
"Flumezapine Hydrochloride is used in the treatment of chronic psychoses such as schizophrenia, and appears to be about equal in effectiveness to low-potency antipsychotics."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.